Literature DB >> 12892105

Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia.

Seiji Fukumoto, Takeyoshi Yamashita.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12892105

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  5 in total

Review 1.  Role of FGF/FGFR signaling in skeletal development and homeostasis: learning from mouse models.

Authors:  Nan Su; Min Jin; Lin Chen
Journal:  Bone Res       Date:  2014-04-29       Impact factor: 13.567

2.  Tumor-induced osteomalacia with normal systemic fibroblast growth factor-23 level.

Authors:  Ambika Amblee; Juanito Uy; Carmencita Senseng; Peter Hart
Journal:  Clin Kidney J       Date:  2014-02-25

3.  Performance of 68Ga-DOTA-SST PET/CT, octreoscan SPECT/CT and 18F-FDG PET/CT in the detection of culprit tumors causing osteomalacia: a meta-analysis.

Authors:  Yuanyuan Jiang; Guozhu Hou; Wuying Cheng
Journal:  Nucl Med Commun       Date:  2020-04       Impact factor: 1.698

Review 4.  FGF/FGFR signaling in health and disease.

Authors:  Yangli Xie; Nan Su; Jing Yang; Qiaoyan Tan; Shuo Huang; Min Jin; Zhenhong Ni; Bin Zhang; Dali Zhang; Fengtao Luo; Hangang Chen; Xianding Sun; Jian Q Feng; Huabing Qi; Lin Chen
Journal:  Signal Transduct Target Ther       Date:  2020-09-02

5.  Higher Fibroblast Growth Factor 23 Levels Are Causally Associated With Lower Bone Mineral Density of Heel and Femoral Neck: Evidence From Two-Sample Mendelian Randomization Analysis.

Authors:  Yue Wang; Hui Wang; Peizhan Chen
Journal:  Front Public Health       Date:  2020-09-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.